Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells

Japanese Journal of Cancer Research

Volumn 87, Issue 2, 1996, Pages 212-220

  Inaba, Makoto ^a   Mitsuhashi, Junko ^a   Sawada, Hiroko ^a   Miike, Naoko ^a   Naoe, Yoshinori ^a   Daimon, Aiko ^a   Koizumi, Kazuhisa ^b   Tsujimoto, Hiroaki ^b   Fukushima, Masakazu ^b  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

2' deoxyinosine; 5 fluorouracil; Anabolizing enzyme; Human stomach cancer line; Mechanism of resistance

Indexed keywords

ANABOLIC AGENT; COMPLEMENTARY DNA; FLUOROURACIL; OROTATE PHOSPHORIBOSYLTRANSFERASE; THYMIDYLATE SYNTHASE; URIDINE KINASE; URIDINE PHOSPHORYLASE;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIGAND BINDING; METABOLIC ACTIVATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0029922396     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03161.x     Document Type: Article

References (32)

1. Bapat, A. R., Zarow, C. and Danenberg, P. V. Human leukemic cells resistant to 5-fluoro-2′-deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides. J. Biol. Chem., 258, 4130-4136 (1983).
2. Fernandes, D. J. and Cranford, S. K. Resistance of CCRF-CEM cloned sublines to 5-fluorodeoxyuridine associated with enhanced phosphatase activities. Biochem. Pharmacol., 34, 125-132 (1985).
3. Sobrero, A. F., Moir, R. D., Bertino, J. R. and Handschumacher, R. E. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2′-deoxyuridine in the HCT-8 human carcinoma line. Cancer Res., 45, 3155-3160 (1985).
4. Sobrero, A. F., Handschumacher, R. E. and Bertino, J. R. Highly selective drug combination for human colon cancer cells resistant in vitro to 5-fluoro-2′-deoxyuridine. Cancer Res., 45, 3161-3163 (1985).
5. Berger, S. H., Jenh, C.-H., Johnson, L. F. and Berger, F. G. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells. Mol. Pharmacol., 28, 461-467 (1985).
6. Berger, S. H. and Berger, F. G. Thymidylate synthase as a determinant of 5-fluoro-2′-deoxyuridine response in human colonic tumor cell lines. Mol. Pharmacol., 34, 474-479 (1988).
7. Berger, S. H., Barbour, K. W. and Berger, F. G. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro2′-deoxyuridine in a human colon tumor cell line. Mol. Pharmacol., 34, 480-484 (1988).
8. Canman, C. E., Tang, H.-Y., Normolle, D. P., Lawrence, T. S. and Maybaum, J. Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity. Proc. Natl. Acad. Sci. USA, 89, 10474-10478 (1992).
9. Barbour, K. W., Hoganson, D. K., Berger, S. H. and Berger, F. G. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2′-deoxyuridine in mammalian and bacterial cells. Mol. Pharmacol., 42, 242-248 (1992).
10. Zhang, Z.-G., Malmberg, M., Yin, M.-B., Slocum, H. K. and Rustum, Y. M. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine. Biochem. Pharmacol., 45, 1157-1164 (1993).
11. Davis, S. T. and Berger, S. H. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2′-deoxyuridine. Mol. Pharmacol, 43, 702-708 (1993).
12. Parker, W. B. and Cheng, Y. C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther., 48, 381-395 (1990).
13. Aschele, C., Sobrero, A., Faderan, M. A. and Bertino, J. R. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res., 52, 1855-1864 (1992).
14. Copur, S., Aiba, K., Drake, J. C., Allegra, C. A. and Chu, E. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem. Pharmacol. 49, 1419-1426 (1995).
15. Houghton, J. A., Maroda, S. J., Jr., Phillips, J. O. and Houghton, P. J. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. Cancer Res., 41, 144-149 (1981).
16. Houghton, J. A., Weiss, K. D., Williams, L. G., Torrance, P. M. and Houghton, P. J. Relationship between 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas- Biochem. Pharmacol., 35, 1351-1358 (1986).
17. Spears, C. P., Gustavsson, B. G., Berne, M., Frösing, R., Bernstein, L. and Hayes, A. A. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Cancer Res., 48, 5894-5900 (1988).
18. Johnston, P. G., Lenz, H.-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V. and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fiuorouracil in human colorectal and gastric tumors. Cancer Res., 55, 1407-1412 (1995).
19. Akiyama, S., Amo, H., Watanabe, T., Matsuyama, M., Sakamoto, J., Imaizumi, M., Ichihashi, H., Kondo, T. and Takagi, H. Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4. Jpn. J. Surg., 18, 438-446 (1988).
20. Monks, A., Scudiero, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Gray-Goodrich, M., Campbell, H., Mayo, J. and Boyd, M. Feasibility of a high-flux anti-cancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst., 83, 757-766 (1991).
21. Inaba, M., Mitsuhashi, J. and Ozawa, S. Kinetic analysis of 5-fluorouracil action against various cancer cells. Jpn. J. Cancer Res., 81, 1039-1044 (1990).
22. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem., 162, 156-159 (1987).
23. Yalowich, J. C. and Kalman, T. I. Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro. Biochem. Pharmacol., 34, 2319-2324 (1985).
24. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K. and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA, 86, 2766-2770 (1989).
25. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B. and Erlich, H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487-491 (1988).
26. Kaneda, S., Nalbantoglu, J., Takeishi, K., Shimizu, K., Gotoh, O., Seno, T. and Ayusawa, D. Structural and functional analysis of the human thymidylate synthase gene. J. Biol. Chem., 265, 20277-20284 (1990).
27. Spears, C. P., Shahinian, A. H., Moran, R. G., Heidelberger, C. and Corbett, T. H. In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res., 42, 450-456 (1982).
28. Grem, J. L. and Fischer, P. H. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels. Cancer Res., 46, 6191-6199 (1986).
29. Peters, G. J., Laurensse, E., Leyva, A., Lankelma, J. and Pinedo, H. M. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5′-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Cancer Res., 46, 20-28 (1986).
30. Berman, A. M. and Human, L. Regulation of 5-phosphoribosyl 1-pyrophosphate and of hypoxanthine uptake and release in human erythrocytes by oxypurine cycling. J. Biol. Chem., 265, 6562-6568 (1990).
31. Inaba, M. and Mitsuhashi, J. Flow cytometric analysis of cell-killing actions of 5-fluorouracil in human colorectal cancer cells. Oncol. Res., 6, 303-309 (1994).
32. Houghton, P. J., Rahman, A., Will, C. L., Dolnick, B. J. and Houghton, J. A. Mutation (s) of the thymidylate synthase gene of human adenocarcinoma cells cause a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates. Cancer Res., 52, 558-565 (1992).